What's new

Human medicines European public assessment report (EPAR): Amvuttra, vutrisiran, Date of authorisation: 15/09/2022, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Amvuttra, vutrisiran, Date of authorisation: 15/09/2022, Revision: 4, Status: Authorised

Mar 25, 2025 - 17:37
 0
Human medicines European public assessment report (EPAR): Amvuttra, vutrisiran, Date of authorisation: 15/09/2022, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Amvuttra, vutrisiran, Date of authorisation: 15/09/2022, Revision: 4, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine...

Next Article

Before Trump admin’s Signal controversy, US diplomats in Kyiv scolded for using app

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Qdenga, Dengue tetravalent vaccine (live, attenuated), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: P/0003/2024

Opinion/decision on a Paediatric investigation plan (PI...

Mar 13, 2025  0

European Shortages Monitoring Platform (ESMP)

European Shortages Monitoring Platform (ESMP)

Mar 11, 2025  0

EMEA-002734-PIP01-19-M01

EMEA-002734-PIP01-19-M01

Mar 25, 2025  0